3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Thyroid Nodule
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Spinal Fractures
1
Skin Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Phyllodes Tumor
1
Pancreatic Neoplasms
1
Osteoporosis
1
Nevus
1
Neoplasms
1
Melanoma
1
Locally Advanced Pancreatic Cancer
1
Liver Cirrhosis
1
Hypertension, Portal
1
Glioma
1
Fibrosis
1
Dysplastic Nevus Syndrome
1
Disease
1
Central Nervous System Neoplasms
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
pembrolizumab
8
Nivolumab
6
Ipilimumab
6
cemiplimab
4
aldesleukin
3
Interleukin-2
3
fludarabine
2
Specimen Handling
2
Niacinamide
2
HhAntag691
2
Cyclophosphamide
2
Blood Specimen Collection
2
Biopsy
2
trametinib
1
spartalizumab
1
sonidegib
1
pertuzumab
1
lifileucel
1
four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate)
1
fludarabine phosphate
1
dabrafenib
1
brodalumab
1
atezolizumab
1
Vitamin A
1
Trastuzumab
1
Tissue Banks
1
Surgical Procedures, Operative
1
Sunscreening Agents
1
Standard of Care
1
Second Harmonic Generation Microscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Skin Neoplasms
×
Diagnostic Imaging
×
Clear all
NCT05446155
2024-01-23
BioMEL
Region Skane
Recruiting
2,000 enrolled